These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 39192303)

  • 1. Epidemiology of Hepatitis C over 28 years of monitoring Canadian blood donors: Insight into a low-risk undiagnosed population.
    O'Brien SF; Ehsani-Moghaddam B; Osmond L; Fan W; Goldman M; Drews SJ
    BMC Public Health; 2024 Aug; 24(1):2319. PubMed ID: 39192303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Declining hepatitis C rates in first-time blood donors: insight from surveillance and case-control risk factor studies.
    O'Brien SF; Fan W; Xi G; Yi QL; Goldman M; Fearon MA; Infante-Rivard C; Chiavetta JA; Willems B; Pi D; Fast M; Delage G
    Transfusion; 2008 May; 48(5):902-9. PubMed ID: 18208409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of human T-cell lymphotropic virus-1/2 in Canada over 33 years: A unique contribution of blood donors to public health surveillance.
    O'Brien SF; Ehsani-Moghaddam B; Goldman M; Osmond L; Fan W; Drews SJ
    Can J Public Health; 2024 Aug; 115(4):611-621. PubMed ID: 38743354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors.
    Flichman DM; Blejer JL; Livellara BI; Re VE; Bartoli S; Bustos JA; Ansola CP; Hidalgo S; Cerda ME; Levin AE; Huenul A; Riboldi V; Treviño EM; Salamone HJ; Nuñez FA; Fernández RJ; Reybaud JF; Campos RH
    BMC Infect Dis; 2014 Apr; 14():218. PubMed ID: 24755089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
    Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
    Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations.
    Wang J; Liu J; Huang Y; Wright DJ; Li J; Zhou Z; He W; Yang T; Yao F; Zhu X; Wen G; Bi X; Tiemuer MH; Wen X; Huang M; Cao R; Yun Z; Lü Y; Ma H; Guo N; Yu Q; Ness P; Shan H;
    Transfusion; 2013 Oct; 53(10 Pt 2):2489-97. PubMed ID: 23781978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the serologic and molecular screening of blood donations for the hepatitis B and C viruses in a Mexican Transfusion Center.
    Chiquete E; Sánchez LV; Becerra G; Quintero A; Maldonado M; Panduro A
    Ann Hepatol; 2005; 4(4):275-8. PubMed ID: 16432494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
    El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
    Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.
    Burton CE; Doucette KE; Mabilangan CA; Plitt SS; Lee BE; Preiksaitis JK
    Transpl Infect Dis; 2016 Aug; 18(4):520-8. PubMed ID: 27226204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on the epidemiology of hepatitis C infection among blood donors in Singapore.
    Wang JE
    J Public Health Med; 1995 Dec; 17(4):387-91. PubMed ID: 8639336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus.
    de Almeida-Neto C; Sabino EC; Liu J; Blatyta PF; Mendrone-Junior A; Salles NA; Leão SC; Wright DJ; Basques FV; Ferreira JE; Busch MP; Murphy EL;
    Transfusion; 2013 Apr; 53(4):827-34. PubMed ID: 22882510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis.
    Gao X; Cui Q; Shi X; Su J; Peng Z; Chen X; Lei N; Ding K; Wang L; Yu R; Wang N
    BMC Infect Dis; 2011 Apr; 11():88. PubMed ID: 21477324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing.
    Murokawa H; Yoshikawa A; Ohnuma H; Iwata A; Katoh N; Miyamoto M; Mine H; Emura H; Tadokoro K;
    Vox Sang; 2005 Jan; 88(1):10-6. PubMed ID: 15663717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus prevalence and incidence estimates among Chinese blood donors.
    Fu P; Lv Y; Zhang H; Liu C; Wen X; Ma H; He T; Ke L; Wu B; Liu J; He M; Liao D; Wang J; Ness P; Liu Y; Shan H;
    Transfusion; 2019 Sep; 59(9):2913-2921. PubMed ID: 31271469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
    Fang CT; Field SP; Busch MP; Heyns Adu P
    Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of hepatitis B in Canadian blood donors.
    O'Brien SF; Xi G; Fan W; Yi QL; Fearon MA; Scalia V; Goldman M
    Transfusion; 2008 Nov; 48(11):2323-30. PubMed ID: 18647366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco.
    Baha W; Foullous A; Dersi N; They-they TP; El alaoui K; Nourichafi N; Oukkache B; Lazar F; Benjelloun S; Ennaji MM; Elmalki A; Mifdal H; Bennani A
    BMC Public Health; 2013 Jan; 13():50. PubMed ID: 23331910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV.
    Orton SL; Stramer SL; Dodd RY; Alter MJ
    Transfusion; 2004 Feb; 44(2):275-81. PubMed ID: 14962320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
    Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
    Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.